Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine
Details for Australian Patent Application No. 2007275653 (hide)
International Classifications
Event Publications
12 March 2009 PCT application entered the National Phase
PCT publication WO2008/011080 Priority application(s): WO2008/011080
23 December 2010 Application Accepted
Published as AU-B-2007275653
12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
12 May 2011 Standard Patent Sealed
19 May 2011 Section 223 Application Allowed
Amgen Inc. The time in which to pay the acceptance fee has been extended to 23 Apr 2011. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007275654-WSX-1/p28 as a target for antiinflammatory responses
2007275651-Humeral head resurfacing implant and methods of use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser